Skip to main content
Blog

Live healthier, stronger and sharper for longer

Short, frequent pieces on what changed in the science of ageing well — and our research library holds the deep dives.

Showing 11 of 513 posts Clear filters
ARA-290 (Cibinetide): 2026 Evidence & Neuropathic Pain Relief
Peptides
ARA-290CibinetideNeuropathy

ARA-290 (Cibinetide): 2026 Evidence & Neuropathic Pain Relief

Unpack the newest 2026 evidence surrounding ARA-290 (Cibinetide), focusing on its impact on neuropathic pain, inflammation, and potential revised clinical recommendations.

Sep 14, 20269 min
ARA-290 Stacking & Synergy for Healthspan in 2026:
Peptides
ARA-290CibinetidePeptide Stacking

ARA-290 Stacking & Synergy for Healthspan in 2026:

Discover how ARA-290 (Cibinetide) can be effectively stacked with other compounds to amplify benefits for longevity and healthspan.

Aug 26, 20269 min
ARA-290 (Cibinetide) for Glucose Control &
Peptides
ARA-290CibinetideMetabolic Health

ARA-290 (Cibinetide) for Glucose Control &

Could ARA-290 (Cibinetide) be a game-changer for metabolic health? We dissect the latest research on its effects on glucose control, insulin sensitivity, and body composition.

Aug 26, 202611 min
ARA-290 (Cibinetide): Latest Evidence &
Peptides
ARA-290CibinetideNeuropathy

ARA-290 (Cibinetide): Latest Evidence &

Discover the most recent clinical evidence on ARA-290 (Cibinetide), focusing on its applications in neuropathy and anti-inflammatory pathways, with updated insights for 2026.

Aug 18, 20269 min
ARA-290 (Cibinetide) in the UK: Availability
Peptides
ARA-290CibinetideUK Peptide Law

ARA-290 (Cibinetide) in the UK: Availability

Understanding ARA-290's UK availability and cost is vital. This guide covers legal status, sourcing, pricing, and safety for those considering Cibinetide.

Aug 18, 20269 min
ARA-290 for Healthy Ageing After 50 in 2026: An
Peptides
ARA-290CibinetideHealthy Ageing

ARA-290 for Healthy Ageing After 50 in 2026: An

Could ARA-290 be a valuable tool for healthy ageing? This expert analysis focuses on its benefits and considerations for individuals over 50, exploring its anti-inflammatory and reparative properties.

Aug 17, 20269 min
ARA-290 & Longevity Biomarkers: 2026
Peptides
ARA-290CibinetideLongevity Biomarkers

ARA-290 & Longevity Biomarkers: 2026

Exploring ARA-290's influence on crucial longevity biomarkers, this article dissects the evidence behind its potential to modulate inflammation and cellular ageing pathways.

Aug 11, 20269 min
ARA-290 for Sleep Optimisation in 2026: A Deep
Peptides
ARA-290CibinetideSleep Quality

ARA-290 for Sleep Optimisation in 2026: A Deep

Could ARA-290 be a novel tool for sleep optimisation? This comprehensive review examines its potential to improve sleep architecture, modulate circadian rhythms, and enhance recovery.

Aug 8, 20269 min
ARA-290 Safety: Side Effects & Interactions
Peptides
ARA-290CibinetidePeptides

ARA-290 Safety: Side Effects & Interactions

Delve into the safety profile of ARA-290 (Cibinetide), examining documented side effects, contraindications, and drug interactions to ensure responsible use.

Aug 5, 20269 min
ARA-290 Dosing & Protocols: Optimising
Peptides
ARA-290CibinetideDosing Protocol

ARA-290 Dosing & Protocols: Optimising

Understanding the nuances of ARA-290 (Cibinetide) dosing is crucial for maximising its therapeutic benefits. This guide explores optimal protocols, titration, and cycle strategies.

Aug 2, 20269 min
ARA-290 for Cognition & Focus: A 2026
Peptides
ARA-290CibinetideCognition

ARA-290 for Cognition & Focus: A 2026

Could ARA-290 (Cibinetide) be a game-changer for cognitive function and focus? We examine its mechanisms, clinical evidence, and implications for brain health.

Jul 30, 20269 min

Wondering where to start?

Two minutes, no blood test, no sign-up — find out how you are actually ageing, and what to do about it.

The Sunday briefing

One email a week: what changed in the evidence, what it means for the markers you track, and the occasional thing worth stopping. No spam, unsubscribe anytime.